This $120 million investment is modeled after the American NIH, and it will accelerate the timeline from lab discovery to ...

The United States's dominance in biotech innovation is crucial to our national interests and global security. In recent years, China has quickly become a powerhouse, bolstered by its biotech-friendly ...

I had the opportunity to participate in a panel discussion reflecting on my experiences working with both EBRC and the ...

China’s biotech sector is surging. For the first time, it now leads the world in clinical trials and new drug licensing. The U.S., once the undisputed leader in pharmaceutical innovation, risks losing ...

India's NITI Aayog has unveiled a blueprint for a $691 billion bioeconomy by 2035, proposing a ₹50,000-crore growth fund, six ...

Delve into the hidden innovation system of drug repurposing. When patents expire and commercial value fades, a new wave of ...

A mgen plans to invest more than $600 million in a new, state-of-the-art center for science and innovation at its global headquarters in Thousand Oaks, California. The center is designed to bring ...

Recent Congressional debate over federal funding shuttered a critical pipeline that feeds American biotechnology innovation. On November 17, 2025, the National Institutes of Health (NIH) released a ...

SAN FRANCISCO--(BUSINESS WIRE)--As Demy-Colton and EBD Group’s Biotech Showcase™ concluded its 18 th year, the event continued to distinguish itself as a leading hub for early-stage biotechnology ...

Private equity and venture capital investment in pharma rose 2.1x in five years to $ 731 million for the year ended March ...

The government's ₹1 trillion Research, Development and Innovation (RDI) Fund is set to support its first batch of ...

The 43rd National Pharmaceutical Industry Information Annual Conference and the 2026 Beijing · Changping Life Science Forum opened at Beijing Changping Future Science City on July 12. A Media Snippet ...